Shi Jiazhuang Great Pharmaceutical Co.,Ltd

A single-center, randomized, open, two-period, self-crossover, single-dose design was used to compare the differences in the extent and rate of absorption of arotinolol hydrochloride tablets (10 mg/tablet) produced by Shijiazhuang Grey Pharmaceutical Co., Ltd. and arotinolol hydrochloride tablets (10 mg/tablet, trade name: ALMARE®) produced by Sumitomo Dainippon Pharma Co., Ltd. in healthy Chinese people under fasting and postprandial administration conditions, and to evaluate the safety and tolerability of arotinolol hydrochloride tablets produced by Shijiazhuang Grey Pharmaceutical Co., Ltd.